Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Income from Continuing Operations: 2009-2011

Historic Income from Continuing Operations for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$116.2 million.

  • Lexicon Pharmaceuticals' Income from Continuing Operations fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • Lexicon Pharmaceuticals' Income from Continuing Operations amounted to -$116.2 million in FY2011, which was down 14.19% from -$101.8 million recorded in FY2010.
  • Lexicon Pharmaceuticals' 5-year Income from Continuing Operations high stood at -$93.3 million for FY2009, and its period low was -$116.2 million during FY2011.
  • For the 3-year period, Lexicon Pharmaceuticals' Income from Continuing Operations averaged around -$103.8 million, with its median value being -$101.8 million (2010).
  • Data for Lexicon Pharmaceuticals' Income from Continuing Operations shows a maximum YoY declined of 14.19% (in 2011) over the last 5 years.
  • Over the past 3 years, Lexicon Pharmaceuticals' Income from Continuing Operations (Yearly) stood at -$93.3 million in 2009, then dropped by 9.06% to -$101.8 million in 2010, then fell by 14.19% to -$116.2 million in 2011.